Robert Hedequist
President chez Kineta Immuno-Oncology LLC
Provenance du réseau au premier degré de Robert Hedequist
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Kineta Chronic Pain LLC
 Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Kineta Chronic Pain LLC operates as a biotechnology company. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense systems. The company was founded in 2011 and is headquartered in Seattle, WA.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Kineta Immuno-Oncology LLC
 Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Kineta Immuno-Oncology LLC operates as a biotech company. It specializes in RIG-I pathway, tumor immunity, publications and posters. The company was founded in 2016 and is headquartered in Seattle, WA.
1
| Private Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert Hedequist via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| CBI CO., LTD. | Auto Parts: OEM | Director/Board Member | |
Illumigen Biosciences, Inc.
 Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Pharmaceuticals: Major | Founder | |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder | |
Kineta Viral Hemorrhagic Fever LLC
 Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
| KINETA, INC. | Pharmaceuticals: Major | Founder |
Statistiques
Internationale
| Etats-Unis | 9 |
| Corée du Sud | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Opérationnelle
| Director/Board Member | 7 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Shawn Iadonato | 11 |
- Bourse
- Insiders
- Robert Hedequist
- Connexions Sociétés
